These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 87479)
1. A serologic comparison of Moloney lymphoma cell surface and Moloney oncornavirus antigens. Humphrey D; Tsukamoto-Adey A; Witte OM; Fox R; Jerabek L; Weissman IL J Immunol; 1979 Jul; 123(1):412-8. PubMed ID: 87479 [TBL] [Abstract][Full Text] [Related]
2. Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2. Ng AK; McIntire R; Holden HT; Herberman RB J Immunol; 1978 Sep; 121(3):856-62. PubMed ID: 690439 [No Abstract] [Full Text] [Related]
3. Moloney virus-induced cell surface antigens and histocompatibility antigens are located on distinct molecules. Fox RI; Weissman IL J Immunol; 1979 May; 122(5):1697-704. PubMed ID: 87439 [No Abstract] [Full Text] [Related]
4. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas. Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527 [TBL] [Abstract][Full Text] [Related]
5. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Ng AK; Ames RS; McIntire RK; Herberman RB Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218 [TBL] [Abstract][Full Text] [Related]
6. Moloney lymphoma cells express a polyprotein containing the GAG gene-coded p15 and the Moloney leukemia virus-induced cell surface antigen (MCSA). Karande A; Yefenof E; Fenyö EM; Klein G Int J Cancer; 1979 Apr; 23(4):508-13. PubMed ID: 86525 [TBL] [Abstract][Full Text] [Related]
7. Nature and complexity of the FMR antigenic system. Bismuth A; Kremsdorf D; Debré P; Levy JP Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553 [No Abstract] [Full Text] [Related]
8. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen. Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053 [TBL] [Abstract][Full Text] [Related]
9. Specificity of serum from rodents immune to Moloney C-type virus-induced tumours. Hogg NM Int J Cancer; 1976 Oct; 18(4):439-47. PubMed ID: 61944 [TBL] [Abstract][Full Text] [Related]
10. Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells. Colombo MP; Pierotti MA; Ballinari D; Parmiani G Immunobiology; 1983 Aug; 165(2):186-99. PubMed ID: 6605298 [TBL] [Abstract][Full Text] [Related]
11. In vivo immune selection of a Moloney murine leukemia virus-induced tumor results in the loss of viral- but not tumor-associated antigens. Jiang D; Flyer DC J Immunol; 1990 Nov; 145(10):3502-6. PubMed ID: 1700012 [TBL] [Abstract][Full Text] [Related]
12. Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens. Fenyö EM; Klein E; Klein G; Swiech K J Natl Cancer Inst; 1968 Jan; 40(1):69-89. PubMed ID: 4864597 [No Abstract] [Full Text] [Related]
13. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma. Pearson GR; Redmon LW; Bass LR Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119 [No Abstract] [Full Text] [Related]
14. Antigenic properties and molecular weights of murine leukemia virus-binding proteins. Baird SM J Immunol; 1979 Apr; 122(4):1389-96. PubMed ID: 221574 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice. Lamon EW; Gatti RA; Kiessling R; Fenyö EM Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367 [TBL] [Abstract][Full Text] [Related]
16. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]
17. Deposition of retrovirus associated antigens (p30 and gp70) on cell membranes of feline and murine leukaemia virus infected cells. O'Brien SJ; Simonson JM; Davis S J Gen Virol; 1978 Mar; 38(3):483-96. PubMed ID: 75945 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids. Dillehay DL; Shealy YF; Lamon EW Cancer Res; 1989 Jan; 49(1):44-50. PubMed ID: 2783245 [TBL] [Abstract][Full Text] [Related]
19. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection. Jiang D; Flyer DC J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885 [TBL] [Abstract][Full Text] [Related]
20. Effects of inhibitors of protein and nucleic acid synthesis on the expression of H-2 and Moloney leukemia virus-determined cell-surface antigens on cultured murine lymphoma cells. Cikes M; Klein G J Natl Cancer Inst; 1972 Feb; 48(2):509-15. PubMed ID: 4652384 [No Abstract] [Full Text] [Related] [Next] [New Search]